Event Brief
Mar 4, 2026 at 5:04 AM ET
China Biotech Outlicensing Surges Past $52 Billion
By The BriefBrief
Chinese drug makers see a surge in outlicensing deals, surpassing $52 billion in early 2023.
WHO: Chinese drug makers and global partners
WHAT: Outlicensing deals
WHEN: Mar 4, 2026 at 4:30 AM ET
WHERE: China
WHY: Increased demand for long-term partnerships in drug development
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21432 of 21432
Same format. Every time.
Continue reading — sign in or create a free account with
